XML 83 R54.htm IDEA: XBRL DOCUMENT v3.23.1
Basis of preparation (Details)
$ / shares in Units, € in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2022
EUR (€)
shares
Dec. 31, 2021
EUR (€)
Dec. 31, 2020
EUR (€)
Apr. 30, 2023
EUR (€)
Apr. 30, 2023
USD ($)
Dec. 31, 2022
$ / shares
Jan. 31, 2022
$ / shares
shares
Jan. 01, 2021
EUR (€)
Dec. 31, 2019
EUR (€)
Disclosure of changes in accounting estimates [line items]                  
Number of securities called by warrants | shares 1           1,343,727    
Exercise price of warrants | $ / shares           $ 7.72 $ 7.72    
Share issue related cost € 450 € 0 € 780            
Profit/(loss) (31,841) (46,246) (21,986)            
Comprehensive loss 31,917 45,703 22,034            
Loss before taxes from continuing operations (38,596) (57,422) (59,814)            
Loss for the year from continuing operations (38,703) (57,352) (60,038)            
Loss of operations resulting in operating cash outflow (26,488) (21,739) 8,462            
Accumulated deficit (141,300)                
Equity 7,411 27,258 64,926         € 64,926 € 58,679
Property, plant and equipment 6,808 9,464 16,590         16,590  
Lease liability 15,436 18,724 21,205           21,704
Net income from discontinued operations, net of tax 6,862 11,106 38,052            
Trade receivables and contract assets 16,548 23,462 28,988         28,988  
Other liabilities 202 960 640         640  
Revenue 47,473 42,234 38,453            
Impairment of financial assets   827 3,636            
Accumulated deficit and other reserves (141,265) (109,540) (63,739)         (63,739)  
Short term debt obligation 3,400                
Cash and cash equivalents 35,951 17,818 48,156         48,156 41,095
COVID 19 Segment Discontinued Operations                  
Disclosure of changes in accounting estimates [line items]                  
Loss before taxes from continuing operations 6,875 11,152 38,110            
Net income from discontinued operations, net of tax 6,862 11,106 38,052            
Revenue 19,455 146,334 89,218            
Unadjusted differences identified in trade receivables   (57) (127)            
Unadjusted differences identified in revenue   (57) (127)            
Adjustment                  
Disclosure of changes in accounting estimates [line items]                  
Profit/(loss)   606 (608)            
Comprehensive loss   (606) 608            
Accumulated deficit               € (851)  
Equity   (245) (851)           € (243)
Property, plant and equipment   1,317              
Lease liability   273              
Depreciation expense   (1,317)              
Other operating income (expense)   273              
Net income from discontinued operations, net of tax   1,590              
Trade receivables and contract assets   (875) (211)            
Other liabilities   960 640            
Revenue   (1,355) (710)            
Impairment of financial assets   (313) (102)            
Accumulated deficit and other reserves   (245) (851)            
Adjustment | COVID 19 Segment Discontinued Operations                  
Disclosure of changes in accounting estimates [line items]                  
Unadjusted differences identified in trade receivables   (57) (127)            
Unadjusted differences identified in revenue   € (57) € (127)            
Warrants                  
Disclosure of changes in accounting estimates [line items]                  
Share issue related cost € 68                
Loan and Security Agreement                  
Disclosure of changes in accounting estimates [line items]                  
Prepayments of Borrowings | $         $ 5.0        
Loan and Security Agreement | Minimum                  
Disclosure of changes in accounting estimates [line items]                  
Collateral Amount       € 9,100